This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Regor Pharmaceuticals, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Hailong Li - Innovator in Pharmaceutical Research
Introduction
Hailong Li is an accomplished inventor based in Shanghai, China. He is currently associated with Regor Pharmaceuticals, Inc., where he contributes to innovative research in the pharmaceutical field. Despite having no granted patents to his name, his work is significant in the development of new therapeutic compounds.
Latest Patent Applications
Hailong Li's notable patent application is titled "STING ANTAGONISTS AND USES THEREOF." This application presents compounds of Formula (I), which include pharmaceutically acceptable salts, stereoisomers, or tautomers. These compounds are intended for use in treating conditions where excessive STING activation contributes to the pathology, symptoms, or progression of diseases such as cancer. The disclosure also includes compositions containing these compounds, as well as methods for their use and production.
Conclusion
Hailong Li's contributions to pharmaceutical research, particularly through his latest patent application, highlight his commitment to advancing medical science. His work has the potential to impact the treatment of serious conditions, showcasing the importance of innovation in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile